Europe Small Molecule API Market 2022-2032 by Source (Synthetic, Semi-synthetic, Natural), Product Type (Standard, HPAPI), Therapeutic Area, Application (Clinical, Commercial), Manufacturer Type (Pharma, CMO), and Country: Trend Forecast and Growth Opportunity

November 2023 | 132 pages | ID: EACD720613EDEN
GMD Research

Abstracts

Europe small molecule API market was valued at $43.5 billion in 2022 and will grow by 7.4% annually over 2022-2032, driven by the increasing incidences of diseases, the development of high-potency small molecule APIs, patents expiry of the top-selling pharmaceuticals, the increasing technological developments in manufacturing sector, and a surging healthcare expenditure.

Highlighted with 70 tables and 52 figures, this 132-page report “Europe Small Molecule API Market 2022-2032 by Source (Synthetic, Semi-synthetic, Natural), Product Type (Standard, HPAPI), Therapeutic Area, Application (Clinical, Commercial), Manufacturer Type (Pharma, CMO), and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Europe small molecule API market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe small molecule API market in every aspect of the classification from perspectives of Source, Product Type, Therapeutic Area, Application, Manufacturer Type, and Country.

Based on Source, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Synthetic API
• Branded Synthetic API
• Generic Synthetic API
• Semi-synthetic API
• Natural Origin

Based on Product Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Standard API
• High Potency API (HPAPI)
• Branded HPAPI
• Generic HPAPI

By Therapeutic Area, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Infectious Diseases
• Oncology
• Ophthalmology
• Cardiovascular Disorders
• Central Nervous System
• Respiratory Disorders
• Metabolic Diseases
• Other Therapeutic Areas

By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Clinical Use
• Commercial Use

By Manufacturer Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Pharmaceutical Companies
• CMOs

Geographically, the following national/local markets are fully investigated:

• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

For each key country, detailed analysis and annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Product Type, Therapeutic Area, and Manufacturer Type over the forecast years are also included.

The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

Aurobindo Pharma Ltd.

Cambrex Corporation

Catalent Inc.

Dr. Reddy's Laboratories

GlaxoSmithKline plc

Lonza Group

Merck & Co., Inc.

Mylan N.V.

Novartis AG

Pfizer Inc.

Sun Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.

Wuxi AppTec Co., Ltd.

(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
  2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF EUROPE MARKET BY SOURCE

3.1 Market Overview by Source
3.2 Synthetic API
  3.2.1 Branded Synthetic API
  3.2.2 Generic Synthetic API
3.3 Semi-synthetic API
3.4 Natural Origin

4 SEGMENTATION OF EUROPE MARKET BY PRODUCT TYPE

4.1 Market Overview by Product Type
4.2 Standard API
4.3 High Potency API (HPAPI)
  4.3.1 Branded HPAPI
  4.3.2 Generic HPAPI

5 SEGMENTATION OF EUROPE MARKET BY THERAPEUTIC AREA

5.1 Market Overview by Therapeutic Area
5.2 Infectious Diseases
5.3 Oncology
5.4 Ophthalmology
5.5 Cardiovascular Disorders
5.6 Central Nervous System
5.7 Respiratory Disorders
5.8 Metabolic Diseases
5.9 Other Therapeutic Areas

6 SEGMENTATION OF EUROPE MARKET BY APPLICATION

6.1 Market Overview by Application
6.2 Clinical Use
6.3 Commercial Use

7 SEGMENTATION OF EUROPE MARKET BY MANUFACTURER TYPE

7.1 Market Overview by Manufacturer Type
7.2 Pharmaceutical Companies
7.3 CMOs

8 EUROPEAN MARKET 2022-2032 BY COUNTRY

8.1 Overview of European Market
8.2 Germany
8.3 U.K.
8.4 France
8.5 Spain
8.6 Italy
8.7 Russia
8.8 Rest of European Market

9 COMPETITIVE LANDSCAPE

9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles
Aurobindo Pharma Ltd.
Cambrex Corporation
Catalent Inc.
Dr. Reddy's Laboratories
GlaxoSmithKline plc
Lonza Group
Merck & Co., Inc.
Mylan N.V.
Novartis AG
Pfizer Inc.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Wuxi AppTec Co., Ltd.
RELATED REPORTS

List Of Tables

LIST OF TABLES

Table 1. Snapshot of Europe Small Molecule API Market in Balanced Perspective, 2022-2032
Table 2. World Economic Outlook, 2021-2031
Table 3. World Economic Outlook, 2021-2023
Table 4. Scenarios for Economic Impact of Ukraine Crisis
Table 5. World Health Spending by Region, $ bn, 2013-2020
Table 6. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn
Table 7. Main Product Trends and Market Opportunities in Europe Small Molecule API Market
Table 8. Europe Small Molecule API Market by Source, 2022-2032, $ mn
Table 9. Europe Small Molecule API Market: Synthetic API by Drug Type, 2022-2032, $ mn
Table 10. Europe Small Molecule API Market by Product Type, 2022-2032, $ mn
Table 11. Europe Small Molecule API Market: HPAPI by Drug Type, 2022-2032, $ mn
Table 12. Europe Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn
Table 13. Europe Small Molecule API Market by Application, 2022-2032, $ mn
Table 14. Europe Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn
Table 15. Europe Small Molecule API Market by Country, 2022-2032, $ mn
Table 16. Germany Small Molecule API Market by Product Type, 2022-2032, $ mn
Table 17. Germany Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn
Table 18. Germany Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn
Table 19. U.K. Small Molecule API Market by Product Type, 2022-2032, $ mn
Table 20. U.K. Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn
Table 21. U.K. Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn
Table 22. France Small Molecule API Market by Product Type, 2022-2032, $ mn
Table 23. France Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn
Table 24. France Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn
Table 25. Spain Small Molecule API Market by Product Type, 2022-2032, $ mn
Table 26. Spain Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn
Table 27. Spain Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn
Table 28. Italy Small Molecule API Market by Product Type, 2022-2032, $ mn
Table 29. Italy Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn
Table 30. Italy Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn
Table 31. Russia Small Molecule API Market by Product Type, 2022-2032, $ mn
Table 32. Russia Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn
Table 33. Russia Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn
Table 34. Small Molecule API Market in Rest of Europe by Country, 2022-2032, $ mn
Table 35. Aurobindo Pharma Ltd.: Company Snapshot
Table 36. Aurobindo Pharma Ltd.: Business Segmentation
Table 37. Aurobindo Pharma Ltd.: Product Portfolio
Table 38. Cambrex Corporation: Company Snapshot
Table 39. Catalent Inc.: Company Snapshot
Table 40. Catalent Inc.: Business Segmentation in 2018
Table 41. Catalent Inc.: Product Portfolio
Table 42. Catalent Inc.: Revenue, 2018-2020, $ million
Table 43. Catalent Inc.: Revenue by Region in 2018
Table 44. Dr. Reddy's Laboratories: Company Snapshot
Table 45. Dr. Reddy's Laboratories: Business Segmentation
Table 46. Dr. Reddy's Laboratories: Revenue, 2018-2020, $ bn
Table 47. GlaxoSmithKline: Company Snapshot
Table 48. GlaxoSmithKline: Business Segmentation
Table 49. GlaxoSmithKline: Product Portfolio
Table 50. GlaxoSmithKline: Revenue, 2018-2020, $ bn
Table 51. Lonza Group: Company Snapshot
Table 52. Lonza Group: Business Segmentation in 2018
Table 53. Lonza Group: Product Portfolio
Table 54. Lonza Group: Revenue by Region in 2018
Table 55. Merck & Co., Inc.: Company Snapshot
Table 56. Merck & Co., Inc.: Business Segmentation
Table 57. Merck & Co., Inc.: Revenue, 2018-2020, $ bn
Table 58. Mylan NV: Company Snapshot
Table 59. Mylan NV: Revenue, 2017-2019, $ bn
Table 60. Novartis International AG: Company Snapshot
Table 61. Novartis International AG: Business Segmentation
Table 62. Novartis International AG: Revenue, 2017-2019, $ bn
Table 63. Pfizer Inc.: Company Snapshot
Table 64. Pfizer Inc.: Business Segmentation
Table 65. Pfizer Inc.: Product Portfolio
Table 66. Pfizer Inc.: Revenue, 2018-2020, $ bn
Table 67. Sun Pharmaceutical Industries Limited: Company Snapshot
Table 68. Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 69. Teva Pharmaceutical Industries Ltd.: Business Segmentation
Table 70. WuXi AppTec Inc.: Company Snapshot

List Of Figures

LIST OF FIGURES

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032
Figure 4. Europe Small Molecule API Market, 2022-2032, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Europe Small Molecule API Market
Figure 7. Primary Restraints and Impact Factors of Europe Small Molecule API Market
Figure 8. Investment Opportunity Analysis
Figure 9. Porter’s Fiver Forces Analysis of Europe Small Molecule API Market
Figure 10. Breakdown of Europe Small Molecule API Market by Source, 2022-2032, % of Revenue
Figure 11. Europe Addressable Market Cap in 2023-2032 by Source, Value ($ mn) and Share (%)
Figure 12. Europe Small Molecule API Market by Source: Synthetic API, 2022-2032, $ mn
Figure 13. Europe Small Molecule API Market by Synthetic API: Branded Synthetic API, 2022-2032, $ mn
Figure 14. Europe Small Molecule API Market by Synthetic API: Generic Synthetic API, 2022-2032, $ mn
Figure 15. Europe Small Molecule API Market by Source: Semi-synthetic API, 2022-2032, $ mn
Figure 16. Europe Small Molecule API Market by Source: Natural Origin, 2022-2032, $ mn
Figure 17. Breakdown of Europe Small Molecule API Market by Product Type, 2022-2032, % of Sales Revenue
Figure 18. Europe Addressable Market Cap in 2023-2032 by Product Type, Value ($ mn) and Share (%)
Figure 19. Europe Small Molecule API Market by Product Type: Standard API, 2022-2032, $ mn
Figure 20. Europe Small Molecule API Market by Product Type: High Potency API (HPAPI), 2022-2032, $ mn
Figure 21. Europe Small Molecule API Market by HPAPI: Branded HPAPI, 2022-2032, $ mn
Figure 22. Europe Small Molecule API Market by HPAPI: Generic HPAPI, 2022-2032, $ mn
Figure 23. Breakdown of Europe Small Molecule API Market by Therapeutic Area, 2022-2032, % of Sales Revenue
Figure 24. Europe Addressable Market Cap in 2023-2032 by Therapeutic Area, Value ($ mn) and Share (%)
Figure 25. Europe Small Molecule API Market by Therapeutic Area: Infectious Diseases, 2022-2032, $ mn
Figure 26. Europe Small Molecule API Market by Therapeutic Area: Oncology, 2022-2032, $ mn
Figure 27. Europe Small Molecule API Market by Therapeutic Area: Ophthalmology, 2022-2032, $ mn
Figure 28. Europe Small Molecule API Market by Therapeutic Area: Cardiovascular Disorders, 2022-2032, $ mn
Figure 29. Europe Small Molecule API Market by Therapeutic Area: Central Nervous System, 2022-2032, $ mn
Figure 30. Europe Small Molecule API Market by Therapeutic Area: Respiratory Disorders, 2022-2032, $ mn
Figure 31. Europe Small Molecule API Market by Therapeutic Area: Metabolic Diseases, 2022-2032, $ mn
Figure 32. Europe Small Molecule API Market by Therapeutic Area: Other Therapeutic Areas, 2022-2032, $ mn
Figure 33. Breakdown of Europe Small Molecule API Market by Application, 2022-2032, % of Revenue
Figure 34. Europe Addressable Market Cap in 2023-2032 by Application, Value ($ mn) and Share (%)
Figure 35. Europe Small Molecule API Market by Application: Clinical Use, 2022-2032, $ mn
Figure 36. Europe Small Molecule API Market by Application: Commercial Use, 2022-2032, $ mn
Figure 37. Breakdown of Europe Small Molecule API Market by Manufacturer Type, 2022-2032, % of Revenue
Figure 38. Europe Addressable Market Cap in 2023-2032 by Manufacturer Type, Value ($ mn) and Share (%)
Figure 39. Europe Small Molecule API Market by Manufacturer Type: Pharmaceutical Companies, 2022-2032, $ mn
Figure 40. Breakdown of Europe Small Molecule API In-house Synthesis Market by Region, 2020-2027, % of Revenue
Figure 41. Europe Small Molecule API Market by Manufacturer Type: CMOs, 2022-2032, $ mn
Figure 42. Breakdown of Europe Small Molecule API Contract Synthesis Market by Region, 2020-2027, % of Revenue
Figure 43. Breakdown of European Small Molecule API Market by Country, 2022 and 2032, % of Revenue
Figure 44. Contribution to Europe 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 45. Small Molecule API Market in Germany, 2022-2032, $ mn
Figure 46. Small Molecule API Market in U.K., 2022-2032, $ mn
Figure 47. Small Molecule API Market in France, 2022-2032, $ mn
Figure 48. Small Molecule API Market in Spain, 2022-2032, $ mn
Figure 49. Small Molecule API Market in Italy, 2022-2032, $ mn
Figure 50. Small Molecule API Market in Russia, 2022-2032, $ mn
Figure 51. Small Molecule API Market in Rest of Europe, 2022-2032, $ mn
Figure 52. Growth Stage of Europe Small Molecule API Industry over the Forecast Period